Outcome of patients with osteosarcoma over 40 years of age: Is angiogenesis a marker of survival?

International Seminars in Surgical Oncology

Volumn 3, Issue , 2006, Pages

  Ek, Eugene T H ^a   Ojaimi, Joseline ^a   Kitagawa, Yasuyuki ^a   Choong, Peter F M ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD31 ANTIGEN; CD34 ANTIGEN; CISPLATIN; DOXORUBICIN; IFOSFAMIDE; METHOTREXATE; VASCULOTROPIN;

ABSENCE OF SIDE EFFECTS; ADULT; AGE; AGED; AMPUTATION; ARTICLE; BONE BIOPSY; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DEATH; DRUG MEGADOSE; DRUG RESPONSE; DRUG TOLERABILITY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FEMUR; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HUMERUS; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; MALE; ORTHOPEDIC SURGERY; OSTEOSARCOMA; PAGET BONE DISEASE; PELVIS; PREOPERATIVE CARE; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TUMOR VASCULARIZATION; ULNA;

EID: 33645758312     PISSN: 14777800     EISSN: 14777800     Source Type: Journal    
DOI: 10.1186/1477-7800-3-7     Document Type: Article

References (28)

1. Healy JH, Buss D: Radiation and Pagetic osteogenic sarcoma. Clin Orthop Relat Res 1991, 270:128-34.
2. Bedi HS, Kaufman DV, Choong PF, Slavin JL: Osteosarcoma of the scapular arising in osteogenesis imperfecta. Pathology 1999, 31(1):52-54.
3. Carsi B, Rock MG: Primary osteosarcoma in adults older than 40 years. Clin Orthop Relat Res 2002, 397:53-61.
4. Meyers PA, Heller G, Healey J, et al.: Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. J Clin Oncol 1992, 1(10):5-15.
5. Link MP, Goorin AM, Miser AW, et al: The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med 1986,314(25):1600-06.
6. Hasan J, Byers R,Jayson GC: Intra-tumoural microvessel density in human solid tumours. Br J Cancer 2002, 86(10):1566-77.
7. Weidner N, Semple JP, Welch WR, et al: Tumour angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991, 324:1-8.
8. Neidner N, Carroll PR, Flax J, et al.: Tumour angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993, 143:401-9.
9. Maeda K, Chung YS, Takatsuka S, et al.: Tumour angiogenesis as a predictor of recurrence in gastic carcinoma. J Clin Oncol 1995, 13:477-81.
10. Folkman J, Shing Y: Angiogenesis. J Biol Chem 1992, 267(16):10931-4.
11. Mikulic D, Ilic I, Cepulic M, et al.: Tumor angiogenesis and outcome in osteosarcoma. Pediatr Hematol Oncol 2004, 21(7):611-9.
12. Mantadakis E, Kim G, Reisch J, et al.: Lack of prognostic significance of intratumorall angiogenesis in nonmetastatic osteosarcoma. J Pediatr Hematol Oncol 2001, 23(5):286-9.
13. Kreuter M, Bieker R, Bielack SS, et al.: Prognostic relevance of increased angiogenesis in osteosarcoma. Clin Cancer Res 2004, 10(24):8531-7.
14. Vermeulen PB, Gasparini G, Fox SB, et al.: Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J JCancer 1996, 32A (14):2474-84.
15. Grimer RJ, Cannon SR, Taminiau AM, et al.: Osteosarcoma over the age of forty. Eur J Cancer 2003, 39(2):157-63.
16. Bacci G, Ferrari S, Donati D, et al.: Neoadjuvant chemotherapy for osteosarcoma of the extremity in patients in the fourth and fifth decade of life. Oncol Rep 1998, 5(5): 1259-63.
17. Brooks S, Starkie CM, Clarke NM: Osteosarcoma after the fourth decade. A clinico-pathological review. Arch Orthop Trauma Surg 1985, 104(2): 100-5.
18. Huvos AG: Osteogenic sarcoma of bones and soft tissues in older persons. A clinicopathologic analysis of 117 patients older than 60 years. Cancer 1986, 57(7):1442-9.
19. Naka T, Fukuda T, Shinohara N, Iwamoto Y, Sugioka Y, Tsuneyoshi M: Osteosarcoma versus malignant fibrous histiocytoma of bone in patients older than 40 years. A clinicopathologic and immunohistochemical analysis with special reference to malignant fibrous histiocytoma-like osteosarcoma. Cancer 1995, 76(6):972-84.
20. Liotta LA, Steeg PS, Stetler-Stevenson WG: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991, 64(2):327-36.
21. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990, 82(1):4-6.
22. Blood CH, Zetter BR: Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim Biophys Acta 1990, 1032(1):89-118.
23. McNamara DA, Harmey JH, Walsh TN, Redmond HP, Bouchier-Hayes DJ: Significance of angiogenesis in cancer therapy. Br J Surg 1998, 85(8):1044-55.
24. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT: The fms-like tyrosine kinase, a receptor for vascular endotheliall growth factor. Science 1992, 255(5047):989-91.
25. Maeda K, Chung YS, Ogawa Y, et al: Prognostic value of vascular endotheliall growth factor expression in gastric carcinoma. Cancer 1996, 77(5):858-63.
26. Ishigami SI, Arii S, Furutani M, et al.: Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer. Br J Cancer 1998, 78(10):1379-84.
27. Inoue K, Ozeki Y, Suganuma T, Sugiura Y, Tanaka S: Vascular endotheliall growth factor expression in primary esophageal squamous cell carcinoma. Association with angiogenesis and tumor progression. Cancer 1997, 79(2):206-13.
28. Kaya M, Wada T, Akatsuka T, et al.: Vascular endotheliall growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis. Clin Cancer Res 2000, 6(2):572-7.